The latest fashion trends and all the information on international catwalks | Fashion
The latest fashion trends, timely information from all the international catwalks and all the information about the best ‘top models’ in the world
Month: January 2025
Beauty | Everything you need to be more beautiful and fit
Beauty, everything about the world of cosmetics, perfumes and the most innovative treatments; the best makeup tricks, the latest trends in hairdressing, the secrets of celebrities to be radiant, and the keys to feeling good and leading a healthy life.
Spain will manufacture the electric car that Europe needs. And Stellantis’ commitment to Vigo and Zaragoza is the proof
It had been a while since it was rumored but it has been a official communication from Stellantis which has settled the matter: the STLA Small multi-energy platform is awarded to Spain. The Vigo and Zaragoza plants have their future guaranteed by producing the smallest electric or electrified cars of the automotive group. In addition, Stellantis has also confirmed that it is working on a project to modernize the Villaverde plant in Madrid and give it life beyond the current production of the Citroën C4. The announcement of this award is really important for the Galician and Aragonese plant that in recent years They have feared for the future of their jobs. Furthermore, without leaving Aragon, the confirmation that Stellantis will manufacture its electrified B segment cars there is an endorsement of the joint plans that it maintains with CATL to build a huge battery plant for electric cars next to Zaragoza. The electric car that Europe needs to succeed In your path towards cleaner mobilityIn 2025, Europe will have one of its first touchstones. The new emissions regulations will force us to significantly reduce the combustion car market and increase, even if artificially, the market share of electric and plug-in hybrids. Even if this requires reducing the production of vehicles with combustion engines. Manufacturers who do not act in this way will have to face billion-dollar fines which will be calculated from 95 euros for each gram of CO2 exceeded (the fleet average must not be higher than 93.6 gr/km of CO2) and car sold. In addition to balance your production, Stellantis will pay Tesla to reduce their polluting emissions and present themselves to the European Union under the same group. With this panorama, Europe will have to take a breath and cross its fingers before checking If the customer is willing to pay what the manufacturers ask for for smaller electric cars. The reception of those of 25,000 euro vehicles will be key to understand if the goals set regarding emissions are realistic or, on the contrary, have been overestimated. In that price range, compact and smaller electric cars are the ones that will have to be attractive enough to convince potential clients. These cars are the ones that Stellantis will manufacture on the platform STLA Smalla base that allows vehicles mounted on it to achieve ranges of up to 500 kilometers. But, above all, they have the advantage of being multi-energy and, therefore, offering hybrid versions (plug-in or not) of the same car. This platform has been the one that has been awarded to Vigo and Zaragoza. It is an especially important announcement since they keep alive two plants that last year produced 890,000 vehicles (one in every three cars of all national production), according to Five Days. The economic newspaper assures that, although there is no official data, Stellantis’ investment in modernizing the Vigo and Zaragoza lines for its STLA Small will be around 900 million euros and that, in total, 5,000 million euros will be invested in our country if added to the amount of the new CATL battery plant in Zaragoza. This combo of a car production plant and batteries for said cars is great news for workers. It must be taken into account that, beyond European trends, countries such as France They are betting heavily on electric vehicles of the size that Vigo and Zaragoza will manufacture. It is not only a question of how many electric cars are sold in Spain. Furthermore, Spain is positioned as an interesting country to produce automobiles that, in addition to having a lot to gain from customers, are of special interest to manufacturers. The new regulations will force them to sell more electric vehicles, so greater competition is expected at the most reasonable prices. The award of STLA Small also confirms that Spain is making a especially competitive gap between countries willing to manufacture cars that leave very little profit margin for manufacturers. The smaller and more electrified a car is, the less profit a company can make from it, which is why Spain feared that part of the production of these cars would end up in Eastern Europe. Morocco either Türkiye. As is now happening with Stellantis, the Volkswagen Group also confirmed that Martorell will be the indicated factory to produce its smaller electric cars. An investment that also adds a billion-dollar battery plantthat of Sagunto. The energy and labor costs in Spain are being quite an attraction for manufacturers who have important conflict fronts open in Italy either Germanywhere they propose thousands of layoffs or factory closures. Photo | Stellantis In Xataka | The ghost of PureTech engines haunts Stellantis: it will pay for repairs from 2022 to 2024 if these conditions are met
the future where AI works for us from the computer is beginning to become a reality
OpenAI presented ChatGPT in 2022. In 2023 it arrived GPT-4 together with the innovator ‘Her’ style voice mode. In 2024 the reasoning model debuted o1. And 2025? The AI company just announced Operatora product that promises to become one of the great protagonists of the year. Sam Altman and his team have presented live How does this tool work that puts people at the center of the scene? AI agents. Currently, as we’ll see, it can perform some actions in the browser, although the ambition is that, over time, it can handle more sophisticated tasks. This is what Operator looks like in action We are witnessing an initial launch. Operator is still in the research phase, but OpenAI has made a publicly available preliminary version which can be accessed from operator.chatgpt.com. The limitation? That not everyone will be able to have access to it. At the moment, it is only available for ChatGPT Pro users, the level of 200 dollars per month. The company has also noted that access to its latest product is limited to the United States. He has said that “it will take a while” to reach Europe, and that it will be available to more users “in the coming months.” The staggered launch likely responds to regulatory issues, as we have seen in the past with products that landed in the US market first. In development. Images | OpenAI In Xataka | “The objective is not to compete with ChatGPT”: we spoke with the creators of ALIA, the 100% Spanish AI, to understand its future
One guilty twin, another innocent twin: the tragic story of two brothers
Kevin Dugar He closed his eyes as he heard the echo of his cell door closing once again. He had been in an Illinois prison for a decade, facing the weight of a wrongful conviction that had taken away his freedom, his relationship with his daughter and his dreams of a better life. In 2013, when autumn filled the cells with cold, an unexpected letter changed his life: his twin brother, Karl, admitted to being the real person responsible for the crime for which Kevin had been sentenced. Kevin and Karl Dugar shared much more than their identical appearance. They grew up in an impoverished Chicago neighborhood, dressing alike and playing at confusing teachers and friends. They were inseparable, known by their common nickname, “Twin.” “We will always be one,” they used to say as children, but that promise fell apart over time. During their adolescence, both fell under the influence of local gangs. Although Kevin tried to leave that dangerous world behind, Karl sank deeper into violence. On March 22, 2003, that disconnect between their paths came to a head when a rival gang member, Antwan Taylor, was shot and killed. Witnesses described the shooter as a man dressed in black who fled to a nearby park. The police investigation quickly linked the case to the Vice Lords, the gang to which Kevin had belonged. Although there was no physical evidence, The testimonies of 2 witnesses affirmed that he was responsible. One of them, Ronnie Bolden, claimed to be able to distinguish between Kevin and Karl, but did not know their real names. The inconsistencies in the testimonies went unnoticed at the trial, and in 2005 Kevin was sentenced to 54 years in prison. Kevin’s battle to prove his innocence From the beginning, Kevin maintained his innocence. The detectives offered him a deal: confess to the crime in exchange for a reduced sentence. However, he flatly refused. “I am not going to plead guilty to something I did not do,” he declared repeatedly. Despite his efforts and his lawyer’s arguments about the lack of concrete evidence, the jury found him guilty. While Kevin was serving his sentence, Karl visited his brother in prison. Although Kevin shared the details of his case with him, Karl remained silent about his own responsibility. It was 10 long years before Karl confessed the truth in a letter sent from another prison. The confession that defied the judicial system “Brother, I am the one to blame. “I can’t go on living with this,” Karl wrote in the letter Kevin received in 2013. In it, he admitted having been the author of the crime that had destroyed his brother’s life. Kevin was paralyzed as he read the words he had been waiting for for years. Despite the shock, she mustered the courage to ask Karl to turn himself in and testify. In 2016, Karl declared in court that he was responsible for the murder. However, his testimony was dismissed. Prosecutors argued that Karl, who was already serving a 99-year sentence for another crime, had nothing to lose by taking the fall. Even the judge expressed doubts about their credibility, citing the twins’ history of swapping identities to deceive others. Kevin’s case attracted the attention of Northwestern University’s Center on Wrongful Convictions. A team of lawyers and law students took up his case, analyzing the inconsistencies of the trial and the importance of Karl’s confession. They argued that a jury would have reached a different conclusion if they had access to all the evidence. Finally, in 2021, an appeals court granted Kevin a new trial, recognizing that the circumstances of the case warranted review. Although this did not mean an automatic declaration of innocence, it opened the door for Kevin to regain his freedom. On January 25, 2022, Kevin Dugar was released from Cook County Prison after nearly 2 decades behind bars. Although being out of prison is a step forward, his path is far from easy. He currently lives in a halfway house, under strict conditions, while he awaits a final resolution of his case. Kevin faces the challenge of rebuilding his life. He dreams of restoring his relationship with his daughter, who grew up without him, and finding a way to heal after years of injustice. “I have no hard feelings towards Karl. He’s my brother. He is not to blame for my being in prison; “That was the system,” Kevin told The Guardian. However, his words carry an emotional weight that reflects the complexity of his situation. Reflections on an imperfect judicial system Kevin Dugar’s story is not an isolated case. It highlights the systemic failures of a judicial system that often ignores critical evidence and relies excessively on unreliable testimony. Furthermore, it highlights the importance of initiatives such as wrongful conviction centres, which work tirelessly to correct miscarriages of justice. The case also shows the devastating impact of individual decisions in the context of a close family relationship. Karl ultimately chose to confess, but only after years of silence condemned his brother to a life behind bars. Kevin’s future remains uncertain, but his determination to rebuild his life and stand firm in his innocence inspires those fighting against a system that too often fails those who need it most. Keep reading: * Texas father guilty of capital murder after strangling daughter during video call* Iowa man sentenced to 55 years in prison for kidnapping ex-girlfriend* Man sentenced to 9 life sentences for decades of sexual abuse of girls
Four Latinos are among the best shortstops in the Major Leagues
Year by year before the start of each season MLB Network publishes a ranking with the best 10 players by position. He recently released the list of the best shortstops in the Major Leagues for 2025 and four Latinos stand out on it. MLB rankings are based on each player’s performance last season. Combining offensive and defensive statistics and metrics; plus analysis from MLB Network’s research team to put together this list. This year the best shortstop according to MLB Network It’s for Baltimore Orioles youngster Gunnar Henderson. Who last year appeared in the sixth box of the best third basemen and in 2024 played the entire season as shortstop. The first Latino to appear in the ranking is the Puerto Rican Francisco Lindor. Who had a 2024 season that led him to be a finalist for MVP in the National League, while at a defensive level he left a fielding percentage of .979 with 12 errors. Francisco Lindor is the owner of the Mets shortstop.Credit: AP It is not until box seven that we see another Latino on the list. This is the Puerto Rican Carlos Correa, who although he missed a large part of the season He only made five errors in 84 games who played for a fielding percentage of .983. In the eighth box appears the Dominican Elly De La Cruz who had his first full season in the Major Leagues. Playing 160 games and being decisive for the Reds with 67 stolen bases and 25 home runs, although he was the shortstop with the most errors in the Major Leagues, accumulating 29 of them. The ninth place goes to Willy Adames who on the offensive He had an excellent season with 112 RBIs and 32 home runs. While with the glove at shortstop he had a fielding percentage of .963 with 20 errors. Top 10 shortstops, according to MLB Network 1. Gunnar Henderson, Orioles2. Corey Seager, Rangers3. Francisco Lindor, Mets4. Bobby Witt Jr., Royals5. Mookie Betts, Dodgers6. Dansby Swanson, Cubs7. Carlos Correa, Twins8. Elly De La Cruz, Reds9. Willy Adames, Giants10. Trea Turner, Phillies Keep reading:Winners of the next 10 World Series, according to predictionsDates to follow for the 2025 Major League Baseball seasonMets sign left-hander AJ Minter for two years, $22 million
We believed that what we learned from the coronavirus would help us better resist other epidemics. The flu shows us that
Five years have passed since the beginning of the pandemic caused by SARS-CoV-2, the Covid-19 virus. In those first months, some wondered what lessons we could learn of past epidemics, such as the “Spanish flu” of 1919 that we could apply to the new epidemic. The question now is another, the opposite, we could say: what can we learn from the pandemic that will help us with epidemics such as the seasonal flu. And above all, why It seems that we have not learned these lessons still. Although the fight against Covid brought with it extreme measures such as confinement, measures that are neither necessary nor implementable in epidemics like the one we see every winter associated with any of the flu viruses, it is possible to look back to find measures that we can put into practice, especially if we present symptoms associated with the flu or a cold. Perhaps the first lesson that Covid taught us regarding the flu is that it is possible to stop the transmission of this virus: the winter between 2020 and 2021 was the winter without flu: the measures to keep the spread of the coronavirus at bay made the incidence of the flu would fade away. This had another impact: the disappearance of a strain of the virus, the one called B/Yamagata. The extinction of this influenza B lineage It is still shrouded in a certain mystery, but what we do know is that since 2020 there has been no news about this strain. But the pandemic too he left us lessons that we can apply, if not in our daily winter life, at least when we notice the appearance of symptoms that we associate with flu or colds (similar but not identical), such as general malaise, runny nose, irritation of the respiratory tract or fever . The pandemic encouraged the study of the transmission of respiratory viruses, of how aerosols containing these pathogens travel through the air. Some of this knowledge can be useful to experts, being extrapolated to other similar viruses, such as the coronaviruses that cause some of the typical colds of these dates and the flu itself. Keeping distance is one of the advice that health authorities give to those who present these symptoms, something that can undoubtedly remind us of social distancing of the pandemic. The transmission of respiratory viruses is usually similar, and in these cases, keeping a certain distance from the other person can be helpful in preventing contagion. Another recommendation that we can find in the guides is to properly ventilate the spaces. Whether in our home, offices or on public transport, adequate ventilation can also hold the key to avoiding new infections. Of course, masks provide a physical barrier to the spread of the virus. Although health authorities recommend resting and avoiding going outside when we suffer from diseases such as the flu, masks can be of great help in cases where that option is not available. Another useful lesson is in testing. Rapid Coronavirus tests were of great help in keeping the spread of the virus at bay and some tests soon incorporated the possibility of looking for the presence of other pathogens, such as the flu. During the pandemic we became familiar with this type of rapid tests, now a lot cheaper and more affordable that five years ago. However, its current use may not be as widespread as might be expected in the context of seasonal influenza epidemics. Similarly, the pandemic enabled new advances in vaccine development, but also laid the foundation for more efficient vaccination campaigns. Also what has been learned by scientists and authorities may be of help when dealing with annual flu outbreaks. Forgetting what was learned And why do we forget these lessons? Forget it’s part of our natureit may even make sense in many contexts, including Covid. Forgetting can make work easier of our brain, but it is also important for our mental health. The process of forgetting is very visual: we associate the Covid era with images such as masks or empty streets. The memory of masks (or forgetting them) may be especially relevant precisely because it is an element that can make it difficult to spread the flu and other diseases of the respiratory system. The lessons not only can they be valid when considering strategies to deal with seasonal flu. In recent years we have witnessed various bird flu outbreakswith the active outbreak in the United States among the most worrying. The virus has reached numerous people and, although so far no infections have been detected among humans, a few weeks ago the first person died as a result of the outbreak. The ramifications of this outbreak have been significant. The outbreak has not only affected wild and poultry birds, it has also affected cattle and cases have even been detected in the country’s pigs. In recent weeks we saw that the virus was circulating again among poultry in Europe, so the possibility of this zoonosis continuing to spread is not negligible. In Xataka | Thousands of people have survived without suffering from Covid. Now they are helping us learn more about the disease Image | Anna Shvets / CDC
The atlas of side effects (positive and negative) of Ozempic discovered | Health and well-being
All medications have side effects, just take a look at any leaflet to see this. But there are not many cases in which these amount to the main effect. This is what happened a few years ago with GLP-1 agonists, medications used for decades to treat type 2 diabetes that began to demonstrate weight-loss effects. After several reformulations, new commercial brands, such as Ozempic and Wegovy, became an effective way to end obesity. But science is proving that there are many other side effects that could become major ones. GLP-1 is a molecular Swiss army knife, a kind of all-purpose drug. They affect our bodies in ways we still don’t fully understand. But today we are closer to listing. A team of scientists from the University of Washington School of Medicine has published the first detailed atlas of the side effects of these drugs. They have found benefits for cognitive and behavioral health, while revealing an increased risk of developing pancreatitis and kidney conditions. “Until now we had seen anecdotes and reports here and there. “Some people saying that it can affect this or that,” explained its main author, the clinical epidemiologist, in the presentation of the study. Ziyad Al-Aly, from the John J. Cochran Veterans Hospital. “But no one, no one had thoroughly investigated the effectiveness and risks of GLP-1 and all the ways it can affect health.” The study was published this Monday in the journal Nature Medicineshowcase of the best world science. More information “We did an analysis that comprehensively mapped the associations between GLP-1 and 175 potential health effects,” Al-Aly notes. The benefits, beyond weight loss, included a lower risk of substance use disorders and a reduction in suicidal ideation, schizophrenia, and other psychotic disorders. They also observed a reduction in cognitive disorders, such as Alzheimer’s and dementia. And finally, a reduction in the risk of clotting disorders, including stroke. “We found that these drugs have a wide range of beneficial effects, but all this does not come without risks,” warns the expert. The study confirms that, in some cases, they can cause gastrointestinal problems, such as nausea and vomiting. This is quite common and has already been documented in some patients. An increased risk of gastroparesis or stomach paralysis in rare cases and an increased risk of low blood pressure have also been seen. The analysis also notes that the drug may increase the risk of sleep problems and headaches, kidney stones, and drug-induced kidney inflammation. For these reasons, the authors recommend that, when evaluating this treatment, it should always be done under medical supervision and after an individualized analysis. “It is an observational study, although it has a large database and has been carried out for a long time,” he explains. Christopher Moralesan endocrinologist at the Virgen Macarena University Hospital in Seville, who was not involved in the study. The study does not demonstrate, therefore, that the medication is the cause of the listed effects. But these are consistent enough (risk reduction between 10 and 20%) and the database large enough (almost two million patients over three years) to think there is a direct relationship. “With Big Data you can scrape these results in very large databases and this is positive. But we must remember that here we can only verify association, not causality.” The objective of this research, in the words of its own authors, was not to analyze a specific effect and demonstrate causality, but to build an atlas of the association of risks and benefits of this relatively new medicine. “It’s like when Christopher Columbus arrived in America, and he thought about mapping it to get his bearings,” explains Al-Aly. “This is what we are doing, drawing a landscape of benefits and risks.” This opens the door to the possibility that in the future, after many reformulations and research, we can talk about an Ozempic for dementia, alcoholism or Alzheimer’s. There is still a long way to go, but this study has drawn a first map to locate the path. And there are many companies willing to embark on this adventure. There is currently a scientific and commercial race to find the next revolutionary use of GLP-1 agonists. Everyone has in mind the case of Novo Nordisk, the Danish laboratory that presented Ozempic in 2018, and which today has a stock market capitalization of 382,000 million dollars, which makes it the largest company in Europe. This has enormous business and economic implications, but from the scientific world, the question is different. How does an anti-diabetes drug have so many and varied effects? “Medicines don’t work surgically. They are designed to do one thing, but the reality is that this is almost never the case,” reflects Al-Aly. “Biology is complex and multiple, and if you touch one thing you will create a network of various effects.” GLP-1 acts on the intestine, but also on the brain, affecting areas that are involved in impulse control and reward signaling. This would explain why they help mitigate addiction problems. These medications would also affect the blood vessels, and in doing so have a potential effect on the heart. There is research that suggests that they also reduce inflammation, including that of the brain, which could explain their protective effect against neurodegenerative diseases. “But there is also another simpler theory that can explain all these positive health effects,” explains Al-Aly. Obesity is considered a disease in itself, but also the gateway to many others. It is the fifth risk factor for death in the world and every year 2.8 million adults die as a result of this condition. “When we treat obesity, it is normal that this affects other diseases, since it is the mother of them all,” summarizes Al-Aly. The expert has not yet decided, with the available scientific evidence, on which of these two theories has more force. The first would mean that we are talking about a miracle drug with multiple uses. The second would be less profitable for companies, would fill … Read more
‘It’s a chain strategy’
The queen of the mornings, Ana Rosa Quintana, returns to her post. After several days of rumors, it was the presenter herself who confirmed the news during the live broadcast this Wednesday, January 22 on Telecinco: “I’m going back to the mornings. I found out this morning and it’s a programming strategy of the chain. I have been here for 21 years and I am in favor of helping in any way I can,” he began explaining while the statement published by Mediaset was broadcast on the screen. © GTRES Ana Rosa Quintaba leaves her program, AfternoonARafter just over a year of broadcast, as it should be remembered, which premiered on September 18, 2023. Despite the fact that Mediaset’s star presenter began to captain this ship with great enthusiasm, and which they announced as ‘more research, more climate, more style, more life, more emotions, more humor, more at street level and with more heart’. This is… ‘TardeAR’, Finally, its afternoon journey ends next Monday. © GTRES Information that has caught off guard both the collaborators who were with her at the time on the television set and the rest of the workers at her production company, Unicorn Content, who have found out at the same time as the public. “The network will premiere the twentieth season of Ana Rosa’s program next Monday, February 3 (09:00 a.m.). Telecinco thus remodels its morning slot, which will begin with Ana Terradillos at the head of The Critical Look, will continue with Ana Rosa’s program and will conclude with Joaquín Prat in Let’s see“, the presenter began by reading the header of the press release. © Mediaset Of course, Ana Rosa Quintaba wanted to make it clear, in response to Boris Izaguirre’s question, that the AfternoonARwill continue. “It is a source of pride that the network continues to trust our production company to do the entire morning and then the afternoon. We have to rebuild the morning and the afternoon will continue. Thank God that all the programs continue, as a producer it is a relief because all the jobs continue. Very excited, she continued explaining what this change means to her: “My heart is broken. Here I have discovered a lot of friends, but it is also true that I am reunited with my entire team with whom I have been for 18 years. And then now “We are going to walk because there is room for everything.” “My job is my job, but I also have to support my network. I have always been a morning person and I will continue to get up early,” he continued explaining before his nephew, Kike Quintana, appeared on the set: “What I most like What matters to me is knowing what happens to me. They have plugged me in and seeing where I am going to go,” he said, laughing. © Mediaset “Next Monday, February 3, one of the most emblematic brands of the network will return to the mornings of Telecinco, which during its 18 years on broadcast was a benchmark on the strip: ‘The Ana Rosa Program’. Your presenter, Ana Rosa Quintanait will be put again in front of this mythical magazineproduced in collaboration with Unicorn Content, which from Monday to Friday will address the most relevant issues of the present and that in this new stage it will have nnew sections and collaborators”, reads the press release issued by the Fuencarral network. © GTRES
Micheál Martin, sworn in as Prime Minister of Ireland after a chaotic parliamentary session
The lower house of the Irish Parliament (Dáil, in Gaelic) has ratified this Thursday the appointment as prime minister of the leader of Fianna Fáil, Micheál Martin, after a…